Immune checkpoint inhibitors increase the risk of hypothyroidism in patients with primary head and neck cancer compared to other cancers

被引:0
|
作者
Alaber, Omar [1 ]
Chandar, Apoorva [1 ]
Mendiratta, Prateek [1 ]
Patel, Monaliben [1 ]
Hoimes, Chris [1 ]
Lavertu, Pierre [1 ]
Mangla, Ankit [1 ]
机构
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P710
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors Serve as the First-Line Treatment for Advanced Head and Neck Cancer
    Huang, Yan
    Zhou, Hong
    Zhao, Guangyong
    Wang, Meihua
    Luo, Judong
    Liu, Jun
    LARYNGOSCOPE, 2024, 134 (02): : 749 - 761
  • [42] Novel drugs including immune checkpoint inhibitors in combination with radiation therapy for head and neck cancer
    Akimoto, Tetsuo
    ANNALS OF ONCOLOGY, 2021, 32 : S256 - S256
  • [43] Immune Checkpoint Inhibitors Regulate K+ Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients
    Gawali, Vaibhavkumar S.
    Chimote, Ameet A.
    Newton, Hannah S.
    Feria-Garzon, Manuel G.
    Chirra, Martina
    Janssen, Edith M.
    Wise-Draper, Trisha M.
    Conforti, Laura
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Checkpoint inhibitors in head and neck cancer: current knowledge and perspectives
    Samra, Bachar
    Tam, Eric
    Baseri, Babak
    Shapira, Iuliana
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (07) : 1023 - 1030
  • [45] CHECKPOINT INHIBITORS IN HEAD AND NECK CANCER: CURRENT STATUS AND PERSPECTIVES
    Samra, Bachar
    Tam, Eric
    Baseri, Babak
    Shapira, Iuliana
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (03) : 717 - 717
  • [47] Suicide risk among cancer survivors: Head and neck versus other cancers.
    Osazuwa-Peters, Nosayaba
    Simpson, Matthew C.
    Zhao, Longwen
    Boakye, Eric Adjei
    Olomukoro, Stephanie I.
    Varvares, Mark A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07)
  • [48] Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors
    Reyes-Gibby, Cielito C.
    Qdaisat, Aiham
    Ferrarotto, Renata
    Fadol, Anecita
    Bischof, Jason J.
    Coyne, Christopher J.
    Lipe, Demis N.
    Hanna, Ehab Y.
    Shete, Sanjay
    Abe, Jun-Ichi
    Yeung, Sai-Ching J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (03): : 627 - 635
  • [49] Immune Checkpoint Protein for Monitoring Head and Neck Cancer Prognosis
    Lakshmipriya, Thangavel
    Gopinath, Subash C. B.
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [50] IMMUNOGLOBULIN ALLOTYPES IN HEAD AND NECK-CANCER PATIENTS WITH MULTIPLE PRIMARY CANCERS
    DEVRIES, N
    DELANGE, G
    DREXHAGE, HA
    SNOW, GB
    ACTA OTO-LARYNGOLOGICA, 1987, 104 (1-2) : 187 - 191